Tree Pollen
NDC 70163-0029, Acer Negundo, Acer Rubrum, Adrenalinum, Allium Cepa, Arsenicum Iodatum, Betula Nigra, Euphrasia Officinalis, Fraxinus Americana, Histaminum Hydrochloricum, Ligustrum Vulgare, Liquidambar Styraciflua, Morus Alba, Pinus Strobus, Populus Deltoides, Quercus Rubra, Sabadilla, Salix Nigra, Sanguinaria Canadensis, liquid, from NaturalCare.
- Product NDC
- 70163-0029
- Status
- Listed
- Labeler
- NaturalCare
- Dosage form
- LIQUID
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- UNAPPROVED HOMEOPATHIC
- Application
- —
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/70163-0029 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ACER NEGUNDO POLLEN12 [hp_X]/mL
- ACER RUBRUM POLLEN12 [hp_X]/mL
- EPINEPHRINE6 [hp_X]/mL
- ONION6 [hp_X]/mL
- ARSENIC TRIIODIDE6 [hp_X]/mL
- BETULA NIGRA POLLEN12 [hp_X]/mL
- EUPHRASIA STRICTA6 [hp_X]/mL
- FRAXINUS AMERICANA POLLEN12 [hp_X]/mL
- HISTAMINE DIHYDROCHLORIDE12 [hp_X]/mL
- LIGUSTRUM VULGARE POLLEN12 [hp_X]/mL
- LIQUIDAMBAR STYRACIFLUA POLLEN12 [hp_X]/mL
- MORUS ALBA POLLEN12 [hp_X]/mL
- PINUS STROBUS POLLEN12 [hp_X]/mL
- POPULUS DELTOIDES POLLEN12 [hp_X]/mL
- QUERCUS RUBRA POLLEN12 [hp_X]/mL
- SCHOENOCAULON OFFICINALE SEED6 [hp_X]/mL
- SALIX NIGRA POLLEN12 [hp_X]/mL
- SANGUINARIA CANADENSIS ROOT6 [hp_X]/mL
Pharmacologic classes
Adrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Catecholamine [EPC]; Catecholamines [CS]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Non-Standardized Food Allergenic Extract [EPC]; Non-Standardized Pollen Allergenic Extract [EPC]; Non-Standardized Pollen Allergenic Extract [EPC]; Non-Standardized Pollen Allergenic Extract [EPC]; Non-Standardized Pollen Allergenic Extract [EPC]; Non-Standardized Pollen Allergenic Extract [EPC]; Non-Standardized Pollen Allergenic Extract [EPC]; Non-Standardized Pollen Allergenic Extract [EPC]; Non-Standardized Pollen Allergenic Extract [EPC]; Non-Standardized Pollen Allergenic Extract [EPC]; Non-Standardized Pollen Allergenic Extract [EPC]; Pollen [CS]; Pollen [CS]; Pollen [CS]; Pollen [CS]; Pollen [CS]; Pollen [CS]; Pollen [CS]; Pollen [CS]; Pollen [CS]; Pollen [CS]; Vegetable Proteins [CS]; alpha-Adrenergic Agonist [EPC]; beta-Adrenergic Agonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 70163-0029-2 | 70163002902 | 1 BOTTLE, DROPPER in 1 CARTON (70163-0029-2) / 30 mL in 1 BOTTLE, DROPPER (70163-0029-1) |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 70163-0029 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/70163-0029 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 70163-0029. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.